Sonrotoclax (BGB-11417)
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
Arms / Cohorts
Experimental Arm:Part 2, Expansion: Cohorts 1 & 2
Accepting patients
Experimental:Part 2, Expansion: Cohorts 3, 4, & 5
Accepting patients
Experimental:Part 2, Expansion: Cohorts 6 & 7
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.